A Randomized, Double-blind, Vehicle Controlled Study of the Safety and Efficacy of Topical DRM02 in Subjects With Rosacea
Phase of Trial: Phase II
Latest Information Update: 06 Jun 2014
Price : $35 *
At a glance
- Drugs DRM 02 (Primary)
- Indications Rosacea
- Focus Therapeutic Use
- Sponsors Dermira
- 14 Apr 2014 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 12 Feb 2014 Data expected in the second quarter of 2014, according to a Dermira media release.
- 21 Jan 2014 Status changed from recruiting to active, no longer recruiting, according to ClinicalTrials.gov.